Comparative Pharmacology
Head-to-head clinical analysis: NULYTELY FLAVORED versus SUTAB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NULYTELY FLAVORED versus SUTAB.
NULYTELY-FLAVORED vs SUTAB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
NULYTELY-FLAVORED is an osmotic laxative containing polyethylene glycol (PEG) 3350 and electrolytes. It induces diarrhea by retaining water in the colon through osmotic action, thereby cleansing the bowel.
SUTAB is a combination tablet consisting of sodium sulfate, magnesium sulfate, and potassium chloride. It acts as an osmotic laxative by drawing water into the bowel lumen through the osmotic effect of sulfate ions, inducing colonic evacuation. Additionally, magnesium ions enhance this effect by attracting water via osmotic pressure and stimulating the release of cholecystokinin, which promotes peristalsis.
Adult dose: 4 liters of reconstituted solution orally as a single dose, or 240 mL (8 oz) every 10 minutes until 4 liters are consumed, approximately 1-1.5 hours before colonoscopy.
24 tablets administered as 4 tablets every 15 minutes, total dose of 17.5 g sodium sulfate, 3.13 g magnesium sulfate, and 1.64 g potassium sulfate, orally, with water, the evening before colonoscopy.
None Documented
None Documented
Not applicable; PEG 3350 is not significantly absorbed and does not exhibit a terminal elimination half-life in the systemic circulation. Clinical effect is due to local osmotic action in the gut.
Terminal elimination half-life: 6-8 hours in adults with normal renal function; prolonged to 20-40 hours in end-stage renal disease.
Primarily fecal elimination as unabsorbed PEG 3350; minimal systemic absorption (<0.06%). Renal excretion of absorbed fraction is negligible.
Primarily renal excretion (65-75% unchanged) with minor biliary/fecal elimination (<10%). Total body clearance approximates renal blood flow.
Category C
Category C
Osmotic Laxative
Osmotic Laxative